{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:26:20Z","timestamp":1780529180707,"version":"3.54.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.ygyno.2012.09.003","type":"journal-article","created":{"date-parts":[[2012,9,8]],"date-time":"2012-09-08T22:15:20Z","timestamp":1347142520000},"page":"511-515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Human epididymis protein 4 (HE4) and ovarian cancer prognosis"],"prefix":"10.1016","volume":"127","author":[{"given":"Dominique","family":"Trudel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"T\u00eatu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Gr\u00e9goire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Plante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimcho","family":"Bachvarov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Douville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bairati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2012.09.003_bb0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/978-1-60327-492-0_20","article-title":"Epidemiology of ovarian cancer","volume":"472","author":"Permuth-Wey","year":"2009","journal-title":"Methods Mol Biol"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2012.09.003_bb0010","article-title":"Carcinoma of the ovary. FIGO 6th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"issue":"27","key":"10.1016\/j.ygyno.2012.09.003_bb0015","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1200\/JCO.2009.27.4696","article-title":"Phase III trial of carboplatin plus paclitaxel with or without gemcitabine in first-line treatment of epithelial ovarian cancer","volume":"28","author":"du Bois","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2012.09.003_bb0020","series-title":"TNM online","article-title":"Ovarian and fallopian tube cancer","author":"Pecorelli","year":"2006"},{"key":"10.1016\/j.ygyno.2012.09.003_bb0025","series-title":"Ovarian cancer including fallopian tube cancer and primary peritoneal cancer","article-title":"Clinical Practice guidelines in Oncology","year":"2006"},{"issue":"Suppl. 8","key":"10.1016\/j.ygyno.2012.09.003_bb0030","doi-asserted-by":"crossref","first-page":"viii7","DOI":"10.1093\/annonc\/mdi961","article-title":"Consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)","volume":"16","author":"du Bois","year":"2005","journal-title":"Ann Oncol"},{"issue":"Pt 1","key":"10.1016\/j.ygyno.2012.09.003_bb0035","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj20020869","article-title":"A locus on human chromosome 20 contains several genes expressing protease inhibitor domains with homology to whey acidic protein","volume":"368","author":"Clauss","year":"2002","journal-title":"Biochem J"},{"issue":"6","key":"10.1016\/j.ygyno.2012.09.003_bb0040","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1586\/erm.09.39","article-title":"HE4 as a biomarker for ovarian and endometrial cancer management","volume":"9","author":"Li","year":"2009","journal-title":"Expert Rev Mol Diagn"},{"issue":"8","key":"10.1016\/j.ygyno.2012.09.003_bb0045","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.bjc.6605011","article-title":"Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts","volume":"100","author":"Huhtinen","year":"2009","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.ygyno.2012.09.003_bb0050","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1373\/clinchem.2010.157073","article-title":"Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases","volume":"57","author":"Escudero","year":"2011","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.ygyno.2012.09.003_bb0055","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2012.09.003_bb0060","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejogrb.2011.05.021","article-title":"Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer","volume":"158","author":"Paek","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.ygyno.2012.09.003_bb0065","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1245\/s10434-011-1943-5","article-title":"Serum HE4 level is an independent prognostic factor in epithelial ovarian cancer","volume":"19","author":"Kong","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ygyno.2012.09.003_bb0070","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1158\/1055-9965.EPI-11-0635","article-title":"Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management","volume":"20","author":"Bandiera","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.ygyno.2012.09.003_bb0075","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004347-200001000-00003","article-title":"Histopathologic grading of ovarian carcinoma: a review and proposal","volume":"19","author":"Silverberg","year":"2000","journal-title":"Int J Gynecol Pathol"},{"issue":"92(18)","key":"10.1016\/j.ygyno.2012.09.003_bb0080","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1093\/jnci\/92.18.1534","article-title":"Re: new guidelines to evaluate the response to treatment in solid tumors [ovarian cancer]. Gynecologic Cancer Intergroup","volume":"20","author":"Vergote","year":"2000","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.ygyno.2012.09.003_bb0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"23(36)","key":"10.1016\/j.ygyno.2012.09.003_bb0090","doi-asserted-by":"crossref","first-page":"9067","DOI":"10.1200\/JCO.2004.01.0454","article-title":"Reporting recommendations for tumor marker prognostic studies","volume":"20","author":"McShane","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2012.09.003_bb0095","series-title":"Modeling survival data: extending the Cox model","author":"Therneau","year":"2000"},{"issue":"6","key":"10.1016\/j.ygyno.2012.09.003_bb0100","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/bjc.1994.192","article-title":"Statistical aspects of prognostic factor studies in oncology","volume":"69","author":"Simon","year":"1994","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.ygyno.2012.09.003_bb0105","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bjc.6606092","article-title":"HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the risk of ovarian malignancy algorithm","volume":"104","author":"Van Gorp","year":"2011","journal-title":"Br J Cancer"},{"issue":"Suppl. 2","key":"10.1016\/j.ygyno.2012.09.003_bb0110","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.3747\/co.v18i0.939","article-title":"Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective","volume":"18","author":"Oza","year":"2011","journal-title":"Curr Oncol"},{"issue":"5","key":"10.1016\/j.ygyno.2012.09.003_bb0115","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/PAT.0b013e328348a6e7","article-title":"Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis","volume":"43","author":"McCluggage","year":"2011","journal-title":"Pathology"},{"issue":"6","key":"10.1016\/j.ygyno.2012.09.003_bb0120","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2644","article-title":"The biology of ovarian cancer: new opportunities for translation","volume":"9","author":"Bast","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.ygyno.2012.09.003_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ygyno.2010.09.006","article-title":"Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers","volume":"120","author":"Han","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ygyno.2012.09.003_bb0130","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/IGC.0b013e31821e052e","article-title":"Prognostic impact of prechemotherapy serum levels of HER2, CA125, and HE4 in ovarian cancer patients","volume":"21","author":"Steffensen","year":"2011","journal-title":"Int J Gynecol Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812007366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812007366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:32:15Z","timestamp":1758771135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825812007366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0090825812007366"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.09.003","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human epididymis protein 4 (HE4) and ovarian cancer prognosis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}